Facebook Twitter LinkedIn Google Plus RSS

Insmed announces $58M public offering

By ,

Insmed, a pharmaceutical company in the Monmouth Junction section of South Brunswick, announced Wednesday a public offering of 6 million shares of common stock at $10.40 per share. Net proceeds are expected to be approximately $58 million.

Leerink Swann LLC is acting as sole book-running manager for the offering. Lazard Capital Markets LLC and Canaccord Genuity Inc. are acting as co-managers of the offering. Insmed granted the underwriters a 30-day option to purchase 0.9 million additional shares of common stock at the offering price to cover any overallotment.

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!